caa a22 4500 475846923 CHVBK 20180406123916.0 cr unu---uuuuu 170329e20001101xx s 000 0 eng 10.1023/A:1016647407161 doi (NATIONALLICENCE)springer-10.1023/A:1016647407161 Perception of quality of life by patients, partners and treating physicians [Elektronische Daten] [Kerry Wilson, Anthony Dowling, Mohamed Abdolell, Ian Tannock] The objective of the study was to determine possible differences in perception of quality of life (QoL) between patients with metastatic breast or prostate cancer, their partners, and the treating physician. Patients with metastatic breast cancer (n = 71), and metastatic prostate cancer (n = 29), a partner, and the physician each completed the same QoL questionnaire indicating how they perceived the patient's QoL. The European organization for research and treatment of cancer (EORTC) QLQ-C30 questionnaire was used to assess patients with breast cancer and the modified prostate cancer specific quality of life instrument (PROSQOLI) for patients with prostate cancer. There was reasonable agreement in mean scores between patients, and physicians or partners, for many domains of QoL; however, there was substantial discordance between scores when considering individual patients. For patients with metastatic breast cancer, physicians systematically underestimated overall QoL (p = 0.0002), social functioning (p = 0.001), and role functioning (p = 0.008), while partners showed better agreement. With prostate cancer physicians tended to underestimate pain, while mean scores for spouses were more concordant. There is substantial variability between ratings of QoL by physicians or partners, as compared to patient ratings. Medical decisions should be based on information about QoL provided by patients using validated methods. Kluwer Academic Publishers, 2000 Cancer nationallicence Proxy nationallicence Quality of life nationallicence Wilson Kerry Department of Medical Oncology and Haematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada aut Dowling Anthony Department of Medical Oncology and Haematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada aut Abdolell Mohamed Department of Biostatistics, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada aut Tannock Ian Department of Medical Oncology and Haematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada aut Quality of Life Research Kluwer Academic Publishers 9/9(2000-11-01), 1041-1052 0962-9343 9:9<1041 2000 9 11136 https://doi.org/10.1023/A:1016647407161 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1023/A:1016647407161 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Wilson Kerry Department of Medical Oncology and Haematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada aut NATIONALLICENCE 700 1- Dowling Anthony Department of Medical Oncology and Haematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada aut NATIONALLICENCE 700 1- Abdolell Mohamed Department of Biostatistics, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada aut NATIONALLICENCE 700 1- Tannock Ian Department of Medical Oncology and Haematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada aut NATIONALLICENCE 773 0- Quality of Life Research Kluwer Academic Publishers 9/9(2000-11-01), 1041-1052 0962-9343 9:9<1041 2000 9 11136 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer